hemotune’s hard work and effort in developing therapeutic blood purification platform has been recognized by leading market research and consulting company Frost & Sullivan. Awarding hemotune with Technology Leadership Award in Blood Purification Technology, they shared: “Given today’s landscape, Frost & Sullivan believes the company is in a prime position to disrupt the blood purification market.”
Media Release_Frost Sullivan
About HEMEX
HEMEX is a global provider of clinical research services to small and medium-sized life sciences companies in diverse therapeutic areas. By combining extensive clinical expertise, commitment to speed, and dedication to patient-centric approaches, HEMEX supports its clients to complete their clinical trials faster. Advancing healthcare and improving patient outcomes, HEMEX’s priority is ensuring patients can have access to lifesaving therapies within a short clinical journey. Through its subsidiaries, Hemex Germany GmbH and Hemex Benelux AV, the company can also secure project funding through different EU funds. For more information, visit https://hemex.ch/